Proteome Sciences plc
(the "Company")
Holdings in Company and PDMR Shareholding
Proteome Sciences plc (AIM:PRM) received notification from Vulpes Life Sciences Fund ("Vulpes"), of which Martin Diggle, a non-executive director of the Company, is a director and partner, that today, it purchased 105,590 ordinary shares of 1 pence each ("Ordinary Shares") at 5.5 pence per Ordinary Share (the "Transaction"). Following the Transaction, Vulpes (and Mr Diggle) have a beneficial interest in 53,943,715 Ordinary Shares, representing approximately 18.33% of the current issued share capital of the Company.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
Name |
Vulpes Life Sciences Fund |
||||
2. |
Reason for the Notification |
|||||
a) |
Position/status |
Martin Diggle, non-executive director of the Company is a director and partner of Vulpes Life Sciences Fund |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Proteome Sciences plc |
||||
b) |
LEI |
n/a |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the Financial instrument, type of instrument |
Ordinary Shares of 1p each |
||||
Identification code |
GB0003104196 |
|||||
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
c) |
Price(s) and volume(s) 04 January 2017 |
|
||||
d) |
Aggregated information: · Aggregated volume · Price |
105,590 Ordinary Shares of 1 pence each purchased at an average price of 5.5 pence per Ordinary Share |
||||
e) |
Date of the transaction |
04 January 2017 |
||||
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |